Canaccord Genuity
Canaccord Genuity is the global capital markets division of Canaccord Financial Inc. (CF : TSX | CF. : AIM), offering institutional and corporate clients idea-driven investment banking, research, sales and trading services.
The companies has operations in 24 cities worldwide and the ability to list companies on 10 stock exchanges.
-
Black Diamond Therapeutics Reports Second Quarter 2020 Financial Results and Provides Corporate Update
-
Black Diamond Therapeutics to Present at Upcoming Investor Conferences
-
Black Diamond Therapeutics to Present at Upcoming Investor Conferences
-
Black Diamond Therapeutics Announces Closing of Initial Public Offering and Exercise in Full of the Underwriters’ Option to Purchase Additional Shares
-
Black Diamond Therapeutics Announces Closing of Initial Public Offering and Exercise in Full of the Underwriters’ Option to Purchase Additional Shares
-
Black Diamond Therapeutics Announces Closing of Initial Public Offering and Exercise in Full of the Underwriters’ Option to Purchase Additional Shares
-
Black Diamond Therapeutics (BDTX) IPO Opens 74% Higher
-
Black Diamond Therapeutics (BDTX) Prices 10.586M Share IPO at $19/Sh
-
Black Diamond Therapeutics Announces Pricing of Initial Public Offering
-
Black Diamond Therapeutics Announces Pricing of Initial Public Offering
